T. Ahlgren

发表

Clinical and genetic studies of ETV6/ABL1‐positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate

A. Barbouti, M. Höglund, B. Johansson, 2003, British journal of haematology.

Acute myeloid leukemia with inv(16)(p13q22): Involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign

M. Höglund, B. Johansson, F. Mitelman, 2002, American journal of hematology.

The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex

B. Johansson, F. Mitelman, L. Hagmar, 2001, British journal of haematology.

Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia?

B. Johansson, F. Mitelman, L. Hagmar, 2001, Occupational and environmental medicine.

B‐cell precursor t(8;14)(q11;q32)‐positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome

B. Johansson, T. Olofsson, C. Lundin, 2009, European journal of haematology.

Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas

E. Kimby, J. Delabie, H. Holte, 2015, Leukemia & lymphoma.

Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients.

I. Dybedal, O. Linder, L. Kanter‐Lewensohn, 1998, Blood.

Results of risk‐adapted therapy in acute myeloid leukaemia. A long‐term population‐based follow‐up study

A. Wåhlin, M. Höglund, B. Nilsson, 2009, European journal of haematology.

More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML

M. Höglund, M. Hedenus, B. Simonsson, 2003, Bone Marrow Transplantation.

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001

B. Johansson, P. Nilsson, F. Mitelman, 2002, Leukemia.

Randomized Phase II Study and Long-Term Follow-Up of 71 Patients Colony-Stimulating Factor Plus Erythropoietin: Results From a Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte

I. Dybedal, O. Linder, L. Kanter‐Lewensohn, 2009 .

Deletion of chromosome arm 3p in hematologic malignancies

B. Johansson, F. Mitelman, S. Garwicz, 1997, Leukemia.

RT‐PCR analysis of the MOZ‐CBP and CBP‐MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13)

B. Johansson, F. Mitelman, T. Fioretos, 2000, Genes, chromosomes & cancer.

Cytogenetic polyclonality in hematologic malignancies

B. Johansson, P. Nilsson, F. Mitelman, 1999, Genes, chromosomes & cancer.

A single‐center population‐based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender

B. Johansson, P. Nilsson, F. Mitelman, 1999, European journal of haematology.

Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.

M. Rocchi, B. Johansson, C. Lassen, 2004, Human molecular genetics.

Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21)

J. Yokota, B. Johansson, M. Taniwaki, 2000, Genes, chromosomes & cancer.

Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents.

B. Johansson, F. Mitelman, L. Hagmar, 2000, Scandinavian journal of work, environment & health.

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

I. Dybedal, O. Linder, L. Kanter‐Lewensohn, 2003, British journal of haematology.

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

Bengt Simonsson, Olle Linder, U. Olsson‐Strömberg, 2004, The hematology journal : the official journal of the European Haematology Association.

Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures.

B. Johansson, P. Nilsson, F. Mitelman, 2003, Scandinavian journal of work, environment & health.

Survival time in a population-based consecutive series of adult acute myeloid leukemia – the prognostic impact of karyotype during the time period 1976–1993

B. Johansson, F. Mitelman, L. Hagmar, 2000, Leukemia.

Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors

E. Holmberg, A. Waage, A. Odén, 1999, British journal of haematology.